Cyanotech (OTCMKTS:CYAN) Posts Quarterly Earnings Results

Cyanotech (OTCMKTS:CYAN) released its earnings results on Tuesday. The biotechnology company reported $0.12 earnings per share (EPS) for the quarter, Zacks reports. Cyanotech had a negative net margin of 0.25% and a negative return on equity of 0.86%. The firm had revenue of $7.96 million during the quarter.

Cyanotech Price Performance

OTCMKTS:CYAN remained flat at $0.54 during mid-day trading on Thursday. 49,624 shares of the company traded hands, compared to its average volume of 2,121. The stock has a market cap of $4.14 million, a PE ratio of -2.16 and a beta of -0.09. Cyanotech has a one year low of $0.23 and a one year high of $0.78. The stock has a 50 day moving average price of $0.53 and a 200 day moving average price of $0.46. The company has a quick ratio of 0.39, a current ratio of 1.06 and a debt-to-equity ratio of 0.13.

Cyanotech Company Profile

Cyanotech Corporation is a Hawaii-based producer of specialty health and nutrition products derived from microalgae. The company cultivates microalgae in open ponds at its facility on the Kona coast of Hawaii and processes the biomass into nutritional supplements and ingredient products. Its primary products include Hawaiian Spirulina Pacifica, a spirulina-based nutritional supplement, and BioAstin Hawaiian Astaxanthin, a natural antioxidant derived from the microalga Haematococcus pluvialis . Cyanotech has marketed these products for use in dietary supplements, functional foods and other health-related applications.